Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15109 | 662 | 29.3 | 54% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 283 | 18382 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACSDKP | Author keyword | 65 | 81% | 6% | 39 |
| 2 | N ACETYL SERYL ASPARTYL LYSYL PROLINE | Author keyword | 18 | 83% | 2% | 10 |
| 3 | CHROMATIN PEPTIDES | Author keyword | 11 | 100% | 1% | 6 |
| 4 | HEMOREGULATORY PEPTIDE | Author keyword | 9 | 83% | 1% | 5 |
| 5 | AC SDKP | Author keyword | 8 | 56% | 2% | 10 |
| 6 | N ACETYL SERYL ASPARTYL LYSYL PROLINE AC SDKP | Author keyword | 8 | 100% | 1% | 5 |
| 7 | EPIDERMAL PENTAPEPTIDE | Author keyword | 4 | 75% | 0% | 3 |
| 8 | N ACETYL SER ASP LYS PRO | Author keyword | 4 | 75% | 0% | 3 |
| 9 | HEMATOREGULATORY | Author keyword | 3 | 100% | 0% | 3 |
| 10 | SK AND F 107647 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ACSDKP | 65 | 81% | 6% | 39 | Search ACSDKP | Search ACSDKP |
| 2 | N ACETYL SERYL ASPARTYL LYSYL PROLINE | 18 | 83% | 2% | 10 | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE |
| 3 | CHROMATIN PEPTIDES | 11 | 100% | 1% | 6 | Search CHROMATIN+PEPTIDES | Search CHROMATIN+PEPTIDES |
| 4 | HEMOREGULATORY PEPTIDE | 9 | 83% | 1% | 5 | Search HEMOREGULATORY+PEPTIDE | Search HEMOREGULATORY+PEPTIDE |
| 5 | AC SDKP | 8 | 56% | 2% | 10 | Search AC+SDKP | Search AC+SDKP |
| 6 | N ACETYL SERYL ASPARTYL LYSYL PROLINE AC SDKP | 8 | 100% | 1% | 5 | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE+AC+SDKP | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE+AC+SDKP |
| 7 | EPIDERMAL PENTAPEPTIDE | 4 | 75% | 0% | 3 | Search EPIDERMAL+PENTAPEPTIDE | Search EPIDERMAL+PENTAPEPTIDE |
| 8 | N ACETYL SER ASP LYS PRO | 4 | 75% | 0% | 3 | Search N+ACETYL+SER+ASP+LYS+PRO | Search N+ACETYL+SER+ASP+LYS+PRO |
| 9 | HEMATOREGULATORY | 3 | 100% | 0% | 3 | Search HEMATOREGULATORY | Search HEMATOREGULATORY |
| 10 | SK AND F 107647 | 3 | 100% | 0% | 3 | Search SK+AND+F+107647 | Search SK+AND+F+107647 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SERASPENIDE | 45 | 94% | 2% | 16 |
| 2 | TETRAPEPTIDE ACSDKP | 41 | 69% | 5% | 35 |
| 3 | ASP LYS PRO | 29 | 52% | 6% | 40 |
| 4 | ACSDKP | 29 | 72% | 3% | 23 |
| 5 | HEMOREGULATORY PEPTIDE | 19 | 63% | 3% | 19 |
| 6 | AC SDKP | 16 | 53% | 3% | 21 |
| 7 | ASP CYS LYS | 15 | 88% | 1% | 7 |
| 8 | SYNTHETIC TETRAPEPTIDE ACSDKP | 11 | 100% | 1% | 6 |
| 9 | PROTEIN KINASE NII | 11 | 78% | 1% | 7 |
| 10 | STEM CELL PROLIFERATION | 10 | 19% | 7% | 49 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| INHIBITORY PEPTIDES IN HEMATOPOIESIS | 1995 | 28 | 43 | 67% |
| Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis | 2013 | 6 | 81 | 37% |
| Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): Opportunities for angiotensin-converting enzyme inhibitor design | 2013 | 2 | 53 | 64% |
| Pathobiological aspects of the local bone marrow renin-angiotensin system: a review | 2010 | 10 | 44 | 64% |
| The hematopoietic system: a new niche for the renin-angiotensin system | 2006 | 22 | 46 | 37% |
| N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes | 2014 | 1 | 123 | 36% |
| Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system | 2003 | 61 | 85 | 25% |
| Ac-SDKP, a marker of the angiotensin-converting enzyme activity? | 2006 | 1 | 27 | 70% |
| Acidic chromatin peptides. Molecular models and biological activity | 1995 | 2 | 6 | 100% |
| Relevance of renin expression by real-time PCR in acute myeloid leukemia | 2006 | 8 | 30 | 37% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOL MED SCI HUMAN BIOL | 1 | 50% | 0.3% | 2 |
| 2 | SEZ FISIOL BIOFIS | 1 | 17% | 0.9% | 6 |
| 3 | ANTIINFECT THER EUT UNIT | 1 | 50% | 0.2% | 1 |
| 4 | MED BIOL MED BIOL | 1 | 50% | 0.2% | 1 |
| 5 | SEZ NUTR METAB | 1 | 50% | 0.2% | 1 |
| 6 | BOLTZMANN LEUKEMIA | 0 | 33% | 0.2% | 1 |
| 7 | CHEMOTHER Y HEMATOL DIS INTENS CARE | 0 | 33% | 0.2% | 1 |
| 8 | MOL BIOPHYSSINO FRANCE DRUG SCREENIN | 0 | 33% | 0.2% | 1 |
| 9 | UNITA COMPLICANZE DIABET | 0 | 33% | 0.2% | 1 |
| 10 | UNITA FISIOPATOL RENALE | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000192006 | BASIC CANC//SIALOGLYCOPEPTIDE//DENSITY INHIBITION |
| 2 | 0.0000117466 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
| 3 | 0.0000096999 | CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE |
| 4 | 0.0000095243 | B B RAT//CFU SD8//BURST PROMOTING ACTIVITY |
| 5 | 0.0000094712 | CELL AND TISSUE KINETICS//CELL TUMOUR BIOL//H 3 DT |
| 6 | 0.0000079950 | THYMOSIN BETA 4//PROTHYMOSIN ALPHA//THYMOSIN ALPHA 1 |
| 7 | 0.0000068736 | PCR GENE REARRANGEMENT//PH1 POSITIVE ALL//MED CLIN MOLEC BIOL |
| 8 | 0.0000068001 | POSTTRANSPLANT ERYTHROCYTOSIS//POST TRANSPLANT ERYTHROCYTOSIS//ERYTHROCYTOSIS |
| 9 | 0.0000062943 | HEMATOPOIETIC MICROENVIRONMENT//MARROW CULTURE//BONE MARROW STROMA |
| 10 | 0.0000056398 | COLONY PROMOTING ACTIVITY//PHOSPHOAMINO ACIDS//KIDNEY EXTRACT |